More blood pressure medications recalled over cancer-causing chemicals

National
More_blood_pressure_medicine_recalled_du_1_66364488_ver1.0_640_360_1548335946613.jpg

Torrent Pharmaceuticals is expanding its voluntary recall of certain blood pressure medications over trace amounts of a cancer-causing chemical.

Torrent is only recalling lots of losartan-containing medication containing NDEA above the interim acceptable intake limits of 0.27 parts per million (ppm).

The FDA also updated the list of losartan medications under recall. There is also a list of medications not under recall.

The recall is the latest in a series of recalls that started in July over what the FDA describes as ‘unacceptable’ amounts of N-Nitrosodiethylamine (NDEA).

According to the National Institutes of Health, NDEA is a suspected human and animal carcinogen that is used in gasoline as a stabilizer for industrial materials and as a lubricant additive, according to the National Institutes of Health.

The FDA says patients taking any recalled ARB should continue taking their current medicine until their pharmacist provides a replacement or their doctor prescribes a different medication that treats the same condition. Some ARBs contain no NDMA or NDEA.

Copyright 2019 Nexstar Broadcasting, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

news-app-download-apple-350x50news-app-download-android-350x50